Direct virus attack, excessive immune, inflammatory response and dysfunction of HPO axis may all contribute to the abnormal ovary function under COVID-19, leading to ovarian injury at last, including declined ovarian reserve and reproductive endocrine disorder in women with COVID-19. The gene discussed is GFER; the disease is COVID-19.